Yifeng Pharmacy (603939) - Total Liabilities

Latest as of September 2025: CN¥14.41 Billion CNY ≈ $2.11 Billion USD

Based on the latest financial reports, Yifeng Pharmacy (603939) has total liabilities worth CN¥14.41 Billion CNY (≈ $2.11 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Yifeng Pharmacy annual equity growth to track the company's year-over-year net asset growth rate.

Yifeng Pharmacy - Total Liabilities Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's total liabilities have evolved over time, based on quarterly financial data. See Yifeng Pharmacy (603939) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Yifeng Pharmacy Competitors by Total Liabilities

The table below lists competitors of Yifeng Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Centerra Gold Inc TO:CG	Canada	CA$978.73 Million
Science Applications International Corporation Common Stock NASDAQ:SAIC	USA	$3.85 Billion
Archer Aviation Inc NYSE:ACHR	USA	$243.40 Million
Societe LDC SA PA:LOUP	France	€2.12 Billion
OPENLANE, Inc. NYSE:OPLN	USA	$3.36 Billion
Transcend Information Inc TW:2451	Taiwan	NT$52.03 Billion
China Southern Power Grid Technology Co Ltd SHG:688248	China	CN¥1.45 Billion
Vontobel Holding SW:VONN	Switzerland	CHF32.26 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Yifeng Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yifeng Pharmacy market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yifeng Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yifeng Pharmacy (2011–2024)

The table below shows the annual total liabilities of Yifeng Pharmacy from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥16.58 Billion ≈ $2.43 Billion	+21.12%
2023-12-31	CN¥13.69 Billion ≈ $2.00 Billion	+14.87%
2022-12-31	CN¥11.92 Billion ≈ $1.74 Billion	+29.71%
2021-12-31	CN¥9.19 Billion ≈ $1.34 Billion	+28.18%
2020-12-31	CN¥7.17 Billion ≈ $1.05 Billion	+60.49%
2019-12-31	CN¥4.47 Billion ≈ $653.56 Million	+20.77%
2018-12-31	CN¥3.70 Billion ≈ $541.18 Million	+130.72%
2017-12-31	CN¥1.60 Billion ≈ $234.56 Million	+28.65%
2016-12-31	CN¥1.25 Billion ≈ $182.31 Million	+22.47%
2015-12-31	CN¥1.02 Billion ≈ $148.86 Million	+55.27%
2014-12-31	CN¥655.19 Million ≈ $95.87 Million	+24.99%
2013-12-31	CN¥524.21 Million ≈ $76.71 Million	+24.92%
2012-12-31	CN¥419.63 Million ≈ $61.40 Million	-13.86%
2011-12-31	CN¥487.12 Million ≈ $71.28 Million	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$3.99 Billion

CN¥27.24 Billion CNY

Market Cap Rank

#4118 Global

#622 in China

Share Price

CN¥22.47

Change (1 day)

-0.66%

52-Week Range

CN¥17.98 - CN¥26.22

All Time High

CN¥967.78